New Key Statistics Module, Z-Score and F-Score
FRA:BIO Key Ratios
| Market Cap € M | 1,337.52 |
| Enterprise Value € M | 1,833.12 |
| P/E(ttm) | 7.95 |
| PE Ratio without NRI | 7.95 |
| Forward PE Ratio | -- |
| Price/Book | 3.07 |
| Price/Sales | 2.01 |
| Price/Free Cash Flow | 68.11 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 810.00 |
| EPS (TTM) € | 5.16 |
| Beneish M-Score | -1.96 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 7.83 |
| EV-to-EBITDA | 7.83 |
| PEG | -- |
| Shares Outstanding M | 39.57 |
| Net Margin (%) | 25.26 |
| Operating Margin % | 25.87 |
| Pre-tax Margin (%) | 24.02 |
| Quick Ratio | 0.91 |
| Current Ratio | 2.04 |
| ROA % (ttm) | 15.48 |
| ROE % (ttm) | 46.28 |
| ROIC % (ttm) | 18.91 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.56 |
FRA:BIO Number of Guru Trades
FRA:BIO Volume of Guru Trades
Gurus Latest Trades with FRA:BIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:BIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers